[Featured Stock] ABION Rises 10% on News of Major Shareholder Change

ABION is surging following news of a change in its largest shareholder.

As of 2:49 PM on the 19th, ABION is trading at 6,720 KRW, up 10.89% (660 KRW) from the previous trading day.

Earlier, Telcon RF Pharmaceutical announced that it became the largest shareholder by purchasing 2,508,381 common shares of ABION through a block deal (off-hours trading) on the same day. The stake amounts to 20.37%. ABION has disclosed that it is conducting a global Phase 2 clinical trial for its anticancer drug 'ABN401 (Babamekip)'.